STERIS plc — Director's Dealing 2022

Jun 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2022-06-02

Reporting Person: Breeden Richard C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-02	Ordinary Shares	M	3218	$32.36	Acquired	38180	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-02	Director Stock Option (right to buy)	$32.36	M	3218	Disposed	2022-08-03	Ordinary Shares (3218)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	27242	Indirect

Footnotes

F1: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC (the "General Partner") is in turn the general partner of Breeden Partners L.P. (the "Fund").

F2: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,358 of these shares held by Breeden Partnership LLP.

F3: This option to purchase 3,218 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,218 ordinary shares for $32.36 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.